This white paper draws on the collective expertise of ten leading professionals in scientific communications and stakeholder engagement, as well as members of the Medical Affairs Professional Society. Their areas of specialization include medical and scientific communications, omnichannel engagement, digital strategy, medical information and field medical operations.
This article explores key questions on how Medical Affairs teams manage patient engagement across different-sized companies who have variations in focus, resources, and scale.
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we discuss the benefits of taking an analytical approach.
This webinar aims to help viewers articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
This advanced module to Patient Centricity will provide a solid overview of how the industry approaches compliance and governance in patient engagement. A suggested prerequisite to the course is the “Essential Concepts of Patient Centricity” eLearning module.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
This webinar will focus on the role of Medical Affairs to lead patient engagement in clinical development.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.